Combination Low Dose Tissue Type-Plasminogen Activator plus Annexin A2 for Improving Thrombolytic Stroke Therapy
Risk of hemorrhagic transformation, incomplete reperfusion, neurotoxicity and a short treatment time window comprise major challenges for tissue plasminogen activator (tPA) thrombolytic stroke therapy. Improving tPA therapy has become one of the highest priorities in the stroke field. This mini revi...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2015-10-01
|
| Serier: | Frontiers in Cellular Neuroscience |
| Fag: | |
| Online adgang: | http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00397/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
